NCT04790448 2023-02-15Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal CancerSun Yat-sen UniversityPhase 1/2 Completed37 enrolled
NCT01892527 2022-09-09Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High SubjectsIstituto Clinico HumanitasPhase 2 Completed43 enrolled